The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $76.5 in the prior trading day, Prestige Consumer Healthcare Inc (NYSE: PBH) closed at $76.42, down -0.10%. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 0.63 million shares were traded. PBH stock price reached its highest trading level at $77.255 during the session, while it also had its lowest trading level at $75.11.
Ratios:
Our goal is to gain a better understanding of PBH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 38.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.46. For the most recent quarter (mrq), Quick Ratio is recorded 2.82 and its Current Ratio is at 4.20. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.56.
On June 21, 2024, DA Davidson Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $65 to $93.
On November 17, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $71.Canaccord Genuity initiated its Buy rating on November 17, 2022, with a $71 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 10 ’25 when Fritz Mary Beth sold 1,678 shares for $90.00 per share. The transaction valued at 151,020 led to the insider holds 17,157 shares of the business.
Fritz Mary Beth bought 1,678 shares of PBH for $151,020 on Mar 10 ’25. On Mar 03 ’25, another insider, Fritz Mary Beth, who serves as the SVP Quality & Regulatory of the company, sold 6,297 shares for $85.39 each. As a result, the insider received 537,701 and left with 18,835 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBH now has a Market Capitalization of 3762416384 and an Enterprise Value of 4892130304. As of this moment, Prestige’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.83, and their Forward P/E ratio for the next fiscal year is 15.21. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.31 while its Price-to-Book (P/B) ratio in mrq is 2.06. Its current Enterprise Value per Revenue stands at 4.3 whereas that against EBITDA is 12.894.
Stock Price History:
The Beta on a monthly basis for PBH is 0.44, which has changed by 0.06434536 over the last 52 weeks, in comparison to a change of 0.10611236 over the same period for the S&P500. Over the past 52 weeks, PBH has reached a high of $90.04, while it has fallen to a 52-week low of $64.94. The 50-Day Moving Average of the stock is -8.60%, while the 200-Day Moving Average is calculated to be -5.30%.
Shares Statistics:
The stock has traded on average 368.01K shares per day over the past 3-months and 470890 shares per day over the last 10 days, according to various share statistics. A total of 49.51M shares are outstanding, with a floating share count of 48.59M. Insiders hold about 1.31% of the company’s shares, while institutions hold 106.14% stake in the company. Shares short for PBH as of 1749772800 were 1658758 with a Short Ratio of 4.52, compared to 1747267200 on 1714758. Therefore, it implies a Short% of Shares Outstanding of 1658758 and a Short% of Float of 4.8699997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
